Related Experiment Video

Updated: May 11, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Left ventricular hypertrophy and microalbuminuria in patients with essential hypertension

Ali Monfared1, Arsalan Salari, Fardin Mirbolok

  • 1Urology Research Center, Department of Nephrology, Guilan University of Medical Sciences, Razi Hospital, Rasht, Iran. drmonfared2009@gmail.com

Iranian Journal of Kidney Diseases
|May 22, 2013
PubMed

Insights

Microalbuminuria is linked to left ventricular hypertrophy (LVH) in essential hypertension patients. This finding highlights microalbuminuria as a key indicator of elevated cardiovascular risk.

Area of Science:

  • Cardiology
  • Nephrology
  • Hypertension Research

Background:

  • Microalbuminuria and left ventricular hypertrophy (LVH) are known predictors of cardiovascular events, particularly in diabetic individuals.
  • Essential hypertension is a major risk factor for cardiovascular disease.

Purpose of the Study:

  • To investigate the association between microalbuminuria and left ventricular hypertrophy (LVH) in patients diagnosed with essential hypertension.
  • To determine if microalbuminuria serves as a predictive marker for LVH in this patient group.

Main Methods:

  • A case-control study involving 110 essential hypertensive patients with LVH and 10 without LVH.
  • Assessment of microalbuminuria using spot urine samples (albumin-creatinine ratio).
  • Evaluation of clinical factors including blood pressure, lipid profile, and serum creatinine.

Main Results:

  • Patients with LVH exhibited significantly higher microalbuminuria levels compared to those without LVH (mean ACR 54.4 vs. 33.56 μg/mg, P < .001).
  • Higher albumin-creatinine ratio was independently associated with LVH (OR, 1.028; P < .001).
  • Diastolic blood pressure, HDL, LDL, and serum creatinine were also significant predictors of LVH.

Conclusions:

  • Left ventricular hypertrophy is significantly associated with microalbuminuria in essential hypertension.
  • These findings reinforce the utility of microalbuminuria as a marker for increased cardiovascular risk in hypertensive patients.
Abstract

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...